
Copyright © All Samadhan - Operated by M/S. Genius Experts | All Rights Reserved
DBID
Registration ID: 176322642
Trade License: TRAD/DNCC/040904/2023

Gonoshasthaya Pharma Ltd. · IM/IV Injection
/ Piece
The information provided on All Samadhan is intended for general informational purposes only and is prepared based on our best practices. It is not a substitute for professional medical advice, diagnosis, or treatment. While we strive to keep the information accurate and up to date, we do not guarantee its completeness or accuracy. The absence of specific information or warnings about any medicine or service should not be considered as an assurance or endorsement by All Samadhan. All Samadhan shall not be held responsible for any consequences arising from the use of this information. We strongly recommend consulting a qualified healthcare professional or physician for any medical concerns, questions, or clarifications.
Used in the treatment of Calcium Gluconate deficiency states & as a dietary supplement when intake may be inadequate In. Calcium Gluconate is used in-
Severe hypoglycemic tetany
Hypoparathyroidism
Vitamin D-deficiency
Osteoporosis and
Extreme hypercalcemia
Calcium gluconate is used to prevent or treat negative calcium balance. It also helps facilitate nerve and muscle performance as well as normal cardiac function.
1-2 ampoules Ca+ Gluconate IM. Daily or every alternate day. Children require 1/2 of adult dose lM injection should be given deep to gluteus medius muscle Using a long needle. This route is not recommended for children.
Acute hypocalcemia: 10-20 ml (2.32-4.64 m.mol)/Kg.
Body weight Fluoride or lead poisoning: 0.3 ml/Kg Body weights.
Neonatal tetany: 0.3 (0.7 m.mo)/Kg body weight.
Co-administration of high calcium doses with thiazide diuretics may result in milk-alkali syndrome and hypercalcaemia. May potentiate digoxin toxicity. Decreases effects of calcium-channel blockers. Enhanced absorption with calcitriol (a vitamin D metabolite).
If Ca+ Gluconate Inj is administrated too rapidly, nausea, vomiting, hot flushes, sweating, hypotension & vasomotor collapse, possibly fatal may occur.
Pregnancy Category C. Either studies in animals have revealed adverse effects on the fetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the fetus.
Impaired renal function; cardiac disease; hypercalcaemia-associated diseases, e.g. sarcoidosis; other malignancies. Pregnancy.
Minerals in bone formation, Specific mineral preparations
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.